Literature DB >> 6740572

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound.

F Forestier, F Daffos, M Capella-Pavlovsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6740572     DOI： 10.1016/0049-3848(84)90260-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  23 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Low molecular weight heparins: a guide to their optimum use in pregnancy.

Authors:  Pierre Laurent; Guy-Vincent Dussarat; Jacques Bonal; Christophe Jego; Philippe Talard; Christian Bouchiat; Gilles Cellarier
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Size of the nanovectors determines the transplacental passage in pregnancy: study in rats.

Authors:  Jerrie S Refuerzo; Biana Godin; Karen Bishop; Srimeenakshi Srinivasan; Shinil K Shah; Sarah Amra; Susan M Ramin; Mauro Ferrari
Journal:  Am J Obstet Gynecol       Date:  2011-04-08       Impact factor: 8.661

4.  Coagulopathies in Pregnancy: What an Obstetrician Ought to Know!

Authors:  Abhay A Bhave
Journal:  J Obstet Gynaecol India       Date:  2019-11-27

Review 5.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 6.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 7.  Oral anticoagulants in the management of venous thromboembolism.

Authors:  John N Makaryus; Jonathan L Halperin; Joe F Lau
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

Review 8.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 9.  Treatment of mechanical valve thrombosis during pregnancy.

Authors:  Calvin Choi; Scott Midwall; Peter Chaille; C R Conti
Journal:  Clin Cardiol       Date:  2007-06       Impact factor: 2.882

10.  Treatment of Venous Thromboembolism in Pregnancy.

Authors:  Wee Shian Chan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.